Lanxess Acquires Asian Biocide Specialist PCTS

The German specialty chemicals group Lanxess has acquired Singapore-based PCTS Specialty Chemicals for an undisclosed amount. The transaction closes with immediate effect.

PCTS specializes in biocides for environmentally friendly water-based paints that meet stringent health and safety, as well as environmental standards. Biocides prevent the deterioration and discoloring of the paints caused by microorganisms.

PCTS employs about 20 people at modern production and laboratory facilities close to Lanxess Singapore headquarters. PCTS recorded sales in the single-digit million euro range in 2012, with 60% of it being generated in China. The company was majority owned by NIPSEA Technologies.

PCTS will be integrated into the Lanxess business unit Material Protection Products (MPP), which belongs to the company's Performance Chemicals segment. The PCTS facility will also become the new Asia-Pacific headquarters of MPP. The business unit acquired the U.S.-based biocide company Verichem and the material protection activities of Switzerland's Syngenta in 2011.

Lanxess has been present in Singapore since 2004 and is the home to about 380 employees. Singapore is also the global headquarters to the Butyl Rubber business unit, which began the commissioning phase of its new plant on Jurong Island in the first quarter. The plant is expected to start commercial production in the third quarter of 2013. In addition, the Performance Butadiene Rubbers business unit broke ground last year for a Nd-PBR plant on Jurong Island. Ian Wood is the company's country representative in Singapore.

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.